Celldex Therapeutics, Inc. - CLDX
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Jan 06, 2026 | SVP AND CFO | M | D | 4,817.0 | 0.0 | 0.0 | 58,815.0 | View | |
| Jan 06, 2026 | SVP AND CFO | M | A | 4,817.0 | 10.38 | 50,000.46 | 32,942.0 | View | |
| Dec 17, 2025 | SR. VP & CBO | M | D | 11,000.0 | 0.0 | 0.0 | 0.0 | View | |
| Dec 17, 2025 | SR. VP & CBO | M | D | 8,333.0 | 0.0 | 0.0 | 5,000.0 | View | |
| Dec 17, 2025 | SR. VP & CBO | M | A | 11,000.0 | 2.78 | 30,580.0 | 20,097.0 | View | |
| Dec 17, 2025 | SR. VP & CBO | M | A | 8,333.0 | 9.0165 | 75,134.49 | 9,097.0 | View | |
| Dec 08, 2025 | SVP & GENERAL COUNSEL | S | D | 4,166.0 | 29.095 | 121,209.77 | 30,796.0 | View | |
| Nov 17, 2025 | — | M | D | 15,750.0 | 0.0 | 0.0 | 7,875.0 | View | |
| Nov 17, 2025 | — | M | D | 26,672.0 | 0.0 | 0.0 | 0.0 | View | |
| Nov 17, 2025 | — | M | D | 6,876.0 | 0.0 | 0.0 | 0.0 | View | |
| Nov 17, 2025 | — | S | D | 49,298.0 | 24.0005 | 1,183,176.65 | 20,833.0 | View | |
| Nov 17, 2025 | — | M | A | 15,750.0 | 22.48 | 354,060.0 | 70,131.0 | View | |
| Nov 17, 2025 | — | M | A | 26,672.0 | 10.38 | 276,855.36 | 54,381.0 | View | |
| Nov 17, 2025 | — | M | A | 6,876.0 | 9.0165 | 61,997.45 | 27,709.0 | View | |
| Nov 12, 2025 | SVP & Chief Commercial Officer | A | A | 100,000.0 | 0.0 | 0.0 | 100,000.0 | View |